Company filings profile · CIK 0001641489

VTv Therapeutics Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for VTv Therapeutics Inc. (VTVT): 4 filings in the last 90 days vs 14 in the prior 90 (filing-velocity cooling ↓ · 0.29×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 7, 2026. Source-linked, daily-refreshed.

Material 8-K events — VTv Therapeutics Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 6, 2026Amendments to Bylaws/Charter; Financial Statements and Exhibits↗
Aug 6, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Jun 29, 2026Item 5.07↗
May 13, 2026Other Events; Financial Statements and Exhibits↗
May 13, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Mar 10, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Mar 10, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Feb 26, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Feb 2, 2026Entry into a Material Agreement↗
Dec 19, 2025Amendments to Bylaws/Charter; Financial Statements and Exhibits↗
Nov 6, 2025Results of Operations (earnings); Financial Statements and Exhibits↗
Sep 10, 2025Regulation FD Disclosure↗

Watch VTv Therapeutics Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jun 29, 20264↗
Jun 29, 20264↗
Jun 29, 20264↗
Jun 29, 20264↗
Jun 29, 20264↗
Feb 18, 20264↗
Feb 18, 20264↗
Sep 25, 20254↗
Sep 5, 20254↗
Sep 5, 20254↗
Jun 12, 20254↗
Jun 12, 20254↗
Jun 12, 20254↗
Jun 12, 20254↗
Jun 12, 20254↗
May 21, 20254↗
May 21, 20253↗

Recent filings

FiledFormDetail
Oct 6, 20268-K Amendments to Bylaws/Charter; Financial Statements and Exhibits ↗
Aug 6, 202610-Q 10-Q ↗
Aug 6, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Jul 29, 2026SCHEDULE 13G/A ↗
Jun 29, 20264 4 ↗
Jun 29, 20268-K Item 5.07 ↗
Jun 29, 20264 FORM 4 ↗
Jun 29, 20264 FORM 4 ↗
Jun 29, 20264 FORM 4 ↗
Jun 29, 20264 FORM 4 ↗
Jun 10, 2026DEFA14A DEFA14A ↗
May 13, 2026424B2 424B2 ↗
May 13, 20268-K Other Events; Financial Statements and Exhibits ↗
May 13, 2026S-8 S-8 ↗
May 13, 202610-Q 10-Q ↗
May 13, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Apr 28, 2026DEF 14A DEF 14A ↗
Apr 16, 2026SCHEDULE 13G/A ↗
Mar 27, 2026SCHEDULE 13G ↗
Mar 10, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Mar 10, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Mar 10, 202610-K 10-K ↗
Feb 26, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Feb 18, 20264 FORM 4 ↗
Feb 18, 20264 FORM 4 ↗
Feb 2, 20268-K Entry into a Material Agreement ↗
Dec 19, 20258-K Amendments to Bylaws/Charter; Financial Statements and Exhibits ↗
Dec 9, 2025SCHEDULE 13D/A ↗
Nov 24, 2025EFFECT Item ; Item ; Item ↗
Nov 20, 2025CORRESP ↗
Nov 12, 2025SCHEDULE 13G/A ↗
Nov 6, 202510-Q 10-Q ↗
Nov 6, 20258-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Oct 3, 2025S-3 S-3 ↗
Sep 25, 2025SCHEDULE 13D/A ↗
Sep 25, 20254 ↗
Sep 10, 20258-K Regulation FD Disclosure ↗
Sep 8, 2025SCHEDULE 13G ↗
Sep 8, 2025SCHEDULE 13G ↗
Sep 5, 20254 ↗